commercialization of prescription products

Evofem Biosciences is a women's sexual and reproductive healthcare company whose mission is to empower women by providing products that give them control and flexibility. Its FDA-approved PHEXXI (lactic acid, citric acid and potassium bitartrate) vaginal gel, launched in 2020, is a first-in-class hormone-free, on-demand prescription contraception. The company also acquired SOLOSEC (secnidazole) 2 g oral granules, an oral antibiotic approved to treat bacterial vaginosis and trichomoniasis with one dose.

Read more

pharmaceutical developmentwomen's sexual and reproductive healthcare